Most Recent

image: CRISPR Therapy to Enter Trials

CRISPR Therapy to Enter Trials

By | July 25, 2016

Researchers in China will use the CRISPR-Cas9 system to edit T cells extracted from patients with cancer before those cells are returned to the body to target malignant ones.

0 Comments

image: Arming Synthetic Bacteria Against Cancer

Arming Synthetic Bacteria Against Cancer

By | July 20, 2016

Researchers engineer bacteria that deliver an anti-tumor toxin in mice before self-destructing. 

0 Comments

image: Distinguishing Circulating Tumor from Normal Cell-Free DNA

Distinguishing Circulating Tumor from Normal Cell-Free DNA

By | July 19, 2016

Fragments of circulating DNA from tumors are around 20 to 30 base pairs shorter than those from healthy cells, researchers report.

0 Comments

A 3-D carbon nanotube mesh enables rat spinal tissue sections to reconnect in culture.

2 Comments

image: 23andMe Markets Genome Kits to Researchers

23andMe Markets Genome Kits to Researchers

By | July 14, 2016

Scientists can now buy the direct-to-consumer sequencing product, and research participants can join 23andMe’s database.

0 Comments

image: Considering Gene Editing

Considering Gene Editing

By | July 12, 2016

An international committee continues its investigation into the ethical and social considerations of precision DNA editing technology with a public meeting held this morning in Washington, DC.

0 Comments

Juno Therapeutics asks the US Food and Drug Administration for permission to restart the CAR-T experiments without chemotherapy.

0 Comments

Mismatched ancestral origins of mitochondrial and nuclear DNA boost mouse health.

1 Comment

image: CRISPR Combats Herpes

CRISPR Combats Herpes

By | July 5, 2016

Scientists use the gene editing technology to target active and latent virus in mammalian cell cultures.

0 Comments

image: A New Way to ID Targets of RNA-Binding Proteins

A New Way to ID Targets of RNA-Binding Proteins

By | July 1, 2016

The catalytic domain of an RNA-editing enzyme is fused with RNA-binding proteins.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech